Budapest, Hungary

Emil Bittner


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1980-1981

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Emil Bittner: Innovator in Pharmaceutical Chemistry

Introduction

Emil Bittner is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new leurosine derivatives. With a total of 4 patents, his work has the potential to impact the treatment of serious medical conditions.

Latest Patents

Bittner's latest patents include innovative formulations of N-Formyl leurosine derivatives. These derivatives are designed in a dosage form that is effective for treating various types of cancer, including lymphoma, leukemia, and Hodgkin's Disease. The patents detail a method of preparation that involves oxidizing leurosine or its acid addition salts, followed by optional formylation and separation of the resulting products.

Career Highlights

Emil Bittner is associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on the synthesis and application of new pharmaceutical compounds, contributing to advancements in cancer treatment.

Collaborations

Bittner has collaborated with several professionals in his field, including Karola Jovanovics and Kalman Szasz. These collaborations have fostered a productive environment for research and innovation in pharmaceutical chemistry.

Conclusion

Emil Bittner's contributions to the field of pharmaceutical chemistry, particularly through his patents on leurosine derivatives, highlight his role as an innovator in medical treatment. His work continues to pave the way for advancements in therapies for serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…